Markets.com Logo

TBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0217$
  • Previous Close
    0.0217$
  • 52 Week Change
    5.07$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.012$ - 5.08$
  • Dividend Per Share
    --
  • Market cap
    39 068$
  • EPS
    -4.0938
  • Beta
    2.783
  • Volume
    --

About

TBIO.US represents the common stock of Translate Bio, Inc., a company formerly focused on developing messenger RNA (mRNA) therapeutics. Translate Bio was acquired by Sanofi in August 2021. Therefore, TBIO.US is no longer actively traded on the stock market, and its price history reflects its value prior to the acquisition. Prior to its acquisition, Translate Bio focused on developing mRNA therapeutics for various diseases, including cystic fibrosis and liver diseases.
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Ghko B|--
Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Ghko B|--
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

Ghko B|--
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Ghko B|--

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Factors

Clinical Trial Results: Positive data boosts investor confidence, driving up demand and stock price. Negative results or trial failures often lead to significant price drops.

Regulatory Approvals: FDA approval of TBIO's drugs or therapies is a major catalyst, increasing revenue potential and stock valuation. Rejections or delays can negatively impact the stock.

Market Sentiment: General market trends, investor optimism or pessimism, and the overall health of the biotechnology sector influence TBIO's stock price.

Competition: The presence of competing products or companies in the same therapeutic area can affect TBIO's market share and stock performance.

Financial Performance: Revenue, earnings, and profitability reports impact investor perception of TBIO's value and future growth prospects.

Partnerships and Acquisitions: Collaborations with other companies or potential acquisition targets can lead to increased stock value.

People Also Watch

Latest news

Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel

Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel

Ghko B|--
Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty

Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty

Ghko B|--
Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?

Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?

Ghko B|--

Latest Education Articles

What Is Mirror Trading and How Does It Work?

What Is Mirror Trading and How Does It Work?

Julian Parker|--
What Is Short Selling? How Shorting Works in CFD Trading

What Is Short Selling? How Shorting Works in CFD Trading

Julian Parker|--
Leverage vs Margin Trading: Key Differences, Examples and Risks

Leverage vs Margin Trading: Key Differences, Examples and Risks

Julian Parker|--
Recommended Topics